Andy L. He

615 citations
6 papers · 438 · 1 hit paper · h-index 5

Impact in

    • Cancer-related Molecular Pathways
    • Lung Cancer Research Studies
    • CAR-T cell therapy research
    • Phagocytosis and Immune Regulation
    • Immune cells in cancer

Papers in

    • Lung Cancer Research Studies 3
    • Cancer Cells and Metastasis 1
    • Cancer-related Molecular Pathways 1
    • Calcium signaling and nucleotide metabolism 1

Andy L. He

6 papers receiving 433 citations

Andy L. He's Hit Papers

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication 2022 · 198 citations
1980+1+2Years since publication50100150

Peers

Andy L. He
Comparison fields: 5 of 50
  • Oncology 154
  • Immunology 122
  • Molecular Biology 212
  • Neurology 44
  • Cell Biology 48
Replace Libenzio Adrian Conti with:
Libenzio Adrian Conti Italy
Laura Lorenzo-Sanz Spain
Philip S. Hodkinson United Kingdom
Batya Barkan Israel
Cristina Sorino Italy
Jeroen Paardekooper Overman Netherlands
Cassandra Thakurdin United States
Maria K. Kondratyev Canada
Xanthe L. Metcalf Australia
Yangzhi Qi China
Andy L. He relative to Libenzio Adrian Conti Italy Libenzio Adrian Conti's profile →
Citations per field
00.5×1.5×2.2×
Libenzio Adrian Conti · 1×
Citations per year

Countries citing papers authored by Andy L. He

Since Specialization
Citations

This map shows the geographic impact of Andy L. He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy L. He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy L. He more than expected).

Fields of papers citing papers by Andy L. He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy L. He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy L. He. The network helps show where Andy L. He may publish in the future.

Co-authors

The 25 scholars most cited alongside Andy L. He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andy L. He Line = papers co-authored together Andy L. He links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
Hit paper breakdown →
2022198
2 2021117
3 202070
4 202031
5 202317
6 20245

About Andy L. He

Andy L. He is a scholar working on Oncology, Physiology, Biotechnology, Pulmonary and Respiratory Medicine and Neurology, having authored 6 papers that have together received 438 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (3 papers), Cancer Research and Treatments (1 paper), Cancer Cells and Metastasis (1 paper), Cancer-related Molecular Pathways (1 paper), Chromatin Remodeling and Cancer (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Calcium signaling and nucleotide metabolism (1 paper) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Oncology (154 citations), Immunology (122 citations), Molecular Biology (212 citations), Neurology (44 citations) and Cell Biology (48 citations). Andy L. He has collaborated with scholars based in United States. Frequent co-authors include Jason Keith Sicklick, Alfredo Molinolo, Sharmeela Kaushal, Michael B. Rose, Alessandra M. E. Holzem, Julie H. Ko, Matt van de Rijn, Dmitri A. Petrov, Yan Ting Shue and Hongchen Cai. Their work appears in journals such as Cell Reports, Biopreservation and Biobanking, Nature Medicine, Nature and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact